abstract |
The present invention relates to a method of treating mammalian neurological diseases by administering hematopoietic growth factors such as granulocyte-colony stimulating factor (GCSF), granulocyte-macrophage colony stimulating factor (GMCSF). The present invention also provides a method for screening compounds that bind to GCSF or GMCSF receptors found on the surface of neuronal cells; It provides neuroprotective, neuroproliferative and / or STAT gene promoting activity. |